Literature DB >> 12107418

The 2001 Canadian Hypertension Recommendations--What is new and what is old but still important.

Norman R C Campbell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12107418

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN： 0828-282X            Impact factor:   5.223


× No keyword cloud information.
  6 in total

1.  2003 Canadian hypertension recommendations. It's not all old hat.

Authors:  Robert J Petrella
Journal:  Can Fam Physician       Date:  2004-04       Impact factor: 3.275

2.  Prevalence of hypertension, its awareness and control in adult population in Japan.

Authors:  A Sekikawa; T Hayakawa
Journal:  J Hum Hypertens       Date:  2004-12       Impact factor: 3.012

3.  Randomised equivalence trial comparing three month and six month follow up of patients with hypertension by family practitioners.

Authors:  Richard V Birtwhistle; Marshall S Godwin; M Dianne Delva; R Ian Casson; Miu Lam; Susan E MacDonald; Rachelle Seguin; Lucia Rühland
Journal:  BMJ       Date:  2004-01-15

4.  Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006.

Authors:  Brenda R Hemmelgarn; Guanmin Chen; Robin Walker; Finlay A McAlister; Hude Quan; Karen Tu; Nadia Khan; Norm Campbell
Journal:  Can J Cardiol       Date:  2008-06       Impact factor: 5.223

5.  Environmental and genetic contribution to hypertension prevalence: data from an epidemiological survey on Sardinian genetic isolates.

Authors:  Ginevra Biino; Gianfranco Parati; Maria Pina Concas; Mauro Adamo; Andrea Angius; Simona Vaccargiu; Mario Pirastu
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

6.  Reducing risk with e-based support for adherence to lifestyle change in hypertension (REACH): protocol for a multicentred randomised controlled trial.

Authors:  Robert P Nolan; Sam Liu; Ross Feldman; Martin Dawes; Susan Barr; Hazel Lynn; Femida Gwardy-Sridhar; Scott G Thomas; Jack Goodman; Paul Oh; Janusz Kaczorowski; Caroline Chessex; Vladimir Hachinski; Kevin Shoemaker
Journal:  BMJ Open       Date:  2013-08-21       Impact factor: 2.692
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.